Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Interobserver Agreement on Clinical Judgment of Work of Breathing in Spontaneously Breathing Children in the Pediatric Intensive Care Unit.

de Groot MG, de Neef M, Otten MH, van Woensel JBM, Bem RA.

J Pediatr Intensive Care. 2020 Mar;9(1):34-39. doi: 10.1055/s-0039-1697679. Epub 2019 Oct 7.

PMID:
31984155
2.

[5-HT3-antagonists as a substitute for metoclopramide and domperidone: a literature review].

Mouch I, Brouwers JR, van 't Riet E, Nieboer P, Otten MH, Jansman FG.

Ned Tijdschr Geneeskd. 2016;160:A9887. Dutch.

PMID:
27677233
3.

MRP8/14 serum levels as a predictor of response to starting and stopping anti-TNF treatment in juvenile idiopathic arthritis.

Anink J, Van Suijlekom-Smit LW, Otten MH, Prince FH, van Rossum MA, Dolman KM, Hoppenreijs EP, ten Cate R, Ursu S, Wedderburn LR, Horneff G, Frosch M, Vogl T, Gohar F, Foell D, Roth J, Holzinger D.

Arthritis Res Ther. 2015 Aug 7;17:200. doi: 10.1186/s13075-015-0723-1.

4.

Bone health of patients with juvenile idiopathic arthritis: a comparison between dual-energy X-ray absorptiometry and digital X-ray radiogrammetry.

Nusman CM, Anink J, Otten MH, van Rossum MA, van Rijn RR, Maas M, van Suijlekom-Smit LW.

Eur J Radiol. 2015 Oct;84(10):1999-2003. doi: 10.1016/j.ejrad.2015.06.015. Epub 2015 Jun 19.

PMID:
26116967
5.

Long-term quality of life and functional outcome of patients with juvenile idiopathic arthritis in the biologic era: a longitudinal follow-up study in the Dutch Arthritis and Biologicals in Children Register.

Anink J, Prince FH, Dijkstra M, Otten MH, Twilt M, ten Cate R, Gorter SL, Koopman-Keemink Y, van Rossum MA, Hoppenreijs EP, van Suijlekom-Smit LW.

Rheumatology (Oxford). 2015 Nov;54(11):1964-9. doi: 10.1093/rheumatology/kev195. Epub 2015 Jun 14.

PMID:
26078219
6.

Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.

Otten MH, Anink J, Prince FH, Twilt M, Vastert SJ, ten Cate R, Hoppenreijs EP, Armbrust W, Gorter SL, van Pelt PA, Kamphuis SS, Dolman KM, Swart JF, van den Berg JM, Koopman-Keemink Y, van Rossum MA, Wulffraat NM, van Suijlekom-Smit LW.

Ann Rheum Dis. 2015 Jul;74(7):1379-86. doi: 10.1136/annrheumdis-2013-204641. Epub 2014 Mar 18.

PMID:
24641940
7.

[Domperidone: off the market or freely available?].

Otten MH.

Ned Tijdschr Geneeskd. 2013;157(45):A6950. Dutch.

PMID:
24191929
8.

Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients.

Muller PC, Anink J, Shi J, Levarht EW, Reinards TH, Otten MH, van Tol MJ, Jol-van der Zijde CM, Brinkman DM, Allaart CF, Hoppenreijs EP, Koopman-Keemink Y, Kamphuis SS, Dolman K, van den Berg JM, van Rossum MA, van Suijlekom-Smit LW, Schilham MW, Huizinga TW, Toes RE, Ten Cate R, Trouw LA.

Ann Rheum Dis. 2013 Dec;72(12):2053-5. doi: 10.1136/annrheumdis-2013-203650. Epub 2013 Jul 19. No abstract available.

PMID:
23873877
9.

Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?

Anink J, Otten MH, Gorter SL, Prince FH, van Rossum MA, van den Berg JM, van Pelt PA, Kamphuis S, Brinkman DM, Swen WA, Swart JF, Wulffraat NM, Dolman KM, Koopman-Keemink Y, Hoppenreijs EP, Armbrust W, ten Cate R, van Suijlekom-Smit LW.

Rheumatology (Oxford). 2013 Sep;52(9):1674-9. doi: 10.1093/rheumatology/ket170. Epub 2013 Jun 4.

PMID:
23740187
10.

Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.

Anink J, Otten MH, Prince FH, Hoppenreijs EP, Wulffraat NM, Swart JF, ten Cate R, van Rossum MA, van den Berg JM, Dolman KM, Koopman-Keemink Y, Armbrust W, Kamphuis S, van Pelt PA, Gorter SL, van Suijlekom-Smit LW.

Rheumatology (Oxford). 2013 Apr;52(4):712-7. doi: 10.1093/rheumatology/kes373. Epub 2012 Dec 24.

PMID:
23267169
11.

Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.

Otten MH, Anink J, Spronk S, van Suijlekom-Smit LW.

Ann Rheum Dis. 2013 Nov;72(11):1806-12. doi: 10.1136/annrheumdis-2012-201991. Epub 2012 Nov 21. Review.

PMID:
23172748
12.

Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial.

Faber J, Berkhout M, Fiedler U, Avlar M, Witteman BJ, Vos AP, Henke M, Garssen J, van Helvoort A, Otten MH, Arends J.

Clin Nutr. 2013 Jun;32(3):338-45. doi: 10.1016/j.clnu.2012.09.009. Epub 2012 Sep 28.

PMID:
23123043
13.

Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register.

Otten MH, Prince FH, Anink J, Ten Cate R, Hoppenreijs EP, Armbrust W, Koopman-Keemink Y, van Pelt PA, Kamphuis S, Gorter SL, Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW.

Ann Rheum Dis. 2013 May;72(5):721-7. doi: 10.1136/annrheumdis-2011-201060. Epub 2012 Jun 23.

PMID:
22730374
14.

The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis.

Holzinger D, Frosch M, Kastrup A, Prince FH, Otten MH, Van Suijlekom-Smit LW, ten Cate R, Hoppenreijs EP, Hansmann S, Moncrieffe H, Ursu S, Wedderburn LR, Roth J, Foell D, Wittkowski H.

Ann Rheum Dis. 2012 Jun;71(6):974-80. doi: 10.1136/annrheumdis-2011-200598. Epub 2012 Jan 20.

PMID:
22267331
15.

Factors associated with treatment response to etanercept in juvenile idiopathic arthritis.

Otten MH, Prince FH, Armbrust W, ten Cate R, Hoppenreijs EP, Twilt M, Koopman-Keemink Y, Gorter SL, Dolman KM, Swart JF, van den Berg JM, Wulffraat NM, van Rossum MA, van Suijlekom-Smit LW.

JAMA. 2011 Dec 7;306(21):2340-7. doi: 10.1001/jama.2011.1671. Epub 2011 Nov 6.

PMID:
22056397
16.

Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.

Otten MH, Prince FH, Twilt M, Ten Cate R, Armbrust W, Hoppenreijs EP, Koopman-Keemink Y, Wulffraat NM, Gorter SL, Dolman KM, Swart JF, van den Berg JM, van Rossum MA, van Suijlekom-Smit LW.

J Rheumatol. 2011 Oct;38(10):2258-63. doi: 10.3899/jrheum.110145. Epub 2011 Aug 15.

PMID:
21844151
17.

Diagnosis and management of juvenile idiopathic arthritis.

Prince FH, Otten MH, van Suijlekom-Smit LW.

BMJ. 2010 Dec 3;341:c6434. doi: 10.1136/bmj.c6434. Review. No abstract available.

PMID:
21131338
18.

Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?

Otten MH, Prince FH, Ten Cate R, van Rossum MA, Twilt M, Hoppenreijs EP, Koopman-Keemink Y, Oranje AP, de Waard-van der Spek FB, Gorter SL, Armbrust W, Dolman KM, Wulffraat NM, van Suijlekom-Smit LW.

Ann Rheum Dis. 2011 Feb;70(2):337-40. doi: 10.1136/ard.2010.135731. Epub 2010 Nov 10.

PMID:
21068101
19.

DIRECT trial. Diverticulitis recurrences or continuing symptoms: Operative versus conservative treatment. A multicenter randomised clinical trial.

van de Wall BJ, Draaisma WA, Consten EC, van der Graaf Y, Otten MH, de Wit GA, van Stel HF, Gerhards MF, Wiezer MJ, Cense HA, Stockmann HB, Leijtens JW, Zimmerman DD, Belgers E, van Wagensveld BA, Sonneveld ED, Prins HA, Coene PP, Karsten TM, Klaase JM, Statius Muller MG, Crolla RM, Broeders IA; Dutch Diverticular Disease (3D) Collaborative Study Group.

BMC Surg. 2010 Aug 6;10:25. doi: 10.1186/1471-2482-10-25.

20.

Disease activity patterns in juvenile systemic lupus erythematosus and its relation to early aggressive treatment.

Otten MH, Cransberg K, van Rossum MA, Groothoff JW, Kist-van Holthe JE, Ten Cate R, Van Suijlekom-Smit LW.

Lupus. 2010 Nov;19(13):1550-6. doi: 10.1177/0961203310374485. Epub 2010 Jul 21.

PMID:
20659970
21.

Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanercept.

Otten MH, Prince FH, Twilt M, van Rossum MA, Armbrust W, Hoppenreijs EP, Kamphuis S, Koopman-Keemink Y, Wulffraat NM, Gorter SL, Ten Cate R, van Suijlekom-Smit LW.

J Rheumatol. 2010 Mar;37(3):665-7. doi: 10.3899/jrheum.090550. Epub 2010 Jan 15.

PMID:
20080910
22.

[Why some proton pump inhibitors are more equal than others].

Otten MH, Lekkerkerker JF, Mulder CJ.

Ned Tijdschr Geneeskd. 2009;153:B414. Dutch.

PMID:
19785839
23.

[Drug treatment of gastro-esophageal reflux disease in pregnant women: consensus guidelines of gastroenterologists and gynaecologists].

Weusten BL, Exalto N, Otten MH.

Ned Tijdschr Geneeskd. 2003 Dec 13;147(50):2471-4. Review. Dutch.

PMID:
14708212
24.

[As-needed treatment with gastric acid inhibitors in gastroesophageal reflux disease].

Poen AC, Otten MH.

Ned Tijdschr Geneeskd. 2003 Aug 23;147(34):1632-6. Review. Dutch.

PMID:
12966628
25.

Alcohol consumption, alcohol dehydrogenase 3 polymorphism, and colorectal adenomas.

Tiemersma EW, Wark PA, Ocké MC, Bunschoten A, Otten MH, Kok FJ, Kampman E.

Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):419-25.

26.

Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome.

Tougas G, Snape WJ Jr, Otten MH, Earnest DL, Langaker KE, Pruitt RE, Pecher E, Nault B, Rojavin MA.

Aliment Pharmacol Ther. 2002 Oct;16(10):1701-8.

27.

A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial.

Mulder CJ, Westerveld BD, Smit JM, Oudkerk Pool M, Otten MH, Tan TG, van Milligen de Wit AW, de Groot GH; Dutch omeprazole MUPS study group.

Eur J Gastroenterol Hepatol. 2002 Jun;14(6):649-56.

PMID:
12072599
28.
29.

[Acute pancreatitis, a protocol for diagnosis and treatment].

van Voorthuizen T, Otten MH.

Ned Tijdschr Geneeskd. 2002 Mar 16;146(11):533; author reply 533-4. Dutch. No abstract available.

PMID:
11925807
30.

Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction.

Gibson CM, Anshelevich M, Murphy S, Luu L, Hynes C, Kliris J, Kermgard S, Otten MH, Antman EM, Cannon CP, Braunwald E; Thrombolysis in Myocardial Infarction.

Am J Cardiol. 2000 Dec 15;86(12):1378-9, A5.

PMID:
11113418
31.
32.

[Meperidine (pethidine) outdated as analgesic in acute pancreatitis].

van Voorthuizen T, Helmers JH, Tjoeng MM, Otten MH.

Ned Tijdschr Geneeskd. 2000 Apr 1;144(14):656-8. Review. Dutch.

PMID:
10774293
33.

[Intestinal infections due to inhibition of gastric acid secretion in reflux disease].

Otten MH.

Ned Tijdschr Geneeskd. 1999 Dec 11;143(50):2511-4. Review. Dutch.

PMID:
10627752
34.
35.
36.

[Fecal analysis for occult blood obsolete].

Otten MH, Rodenburg CJ.

Ned Tijdschr Geneeskd. 1996 Mar 9;140(10):573-4. Dutch. No abstract available.

PMID:
8628415
37.

[Does no Helicobacter pylori mean no duodenal ulcer?].

van Iperen CE, Visser J, Otten MH.

Ned Tijdschr Geneeskd. 1993 Sep 18;137(38):1905-7. Dutch. No abstract available.

PMID:
7779166
38.
39.

Intramural hematoma of the esophagus caused by minor head injury 6 hours previously.

de Vries RA, Kremer-Schneider MM, Otten MH.

Gastrointest Radiol. 1991 Fall;16(4):283-5.

PMID:
1936765
40.

Metabolism of triiodothyronine in rat hepatocytes.

Rooda SJ, Otten MH, van Loon MA, Kaptein E, Visser TJ.

Endocrinology. 1989 Oct;125(4):2187-97.

PMID:
2791985
41.

Effects of inhibition of type I iodothyronine deiodinase and phenol sulfotransferase on the biliary clearance of triiodothyronine in rats.

de Herder WW, Bonthuis F, Rutgers M, Otten MH, Hazenberg MP, Visser TJ.

Endocrinology. 1988 Jan;122(1):153-7.

PMID:
3422065
42.

Metabolism of 3,3'-diiodothyronine in rat hepatocytes: interaction of sulfation with deiodination.

Otten MH, Hennemann G, Docter R, Visser TJ.

Endocrinology. 1984 Sep;115(3):887-94.

PMID:
6745193
43.

Sulfation facilitates hepatic deiodination of iodothyronines.

Visser TJ, Otten MH, Mol JA, Docter R, Hennemann G.

Horm Metab Res Suppl. 1984;14:35-41.

PMID:
6595190
44.

Sulfation preceding deiodination of iodothyronines in rat hepatocytes.

Otten MH, Mol JA, Visser TJ.

Science. 1983 Jul 1;221(4605):81-3.

PMID:
6857270
45.

Rapid deiodination of triiodothyronine sulfate by rat liver microsomal fraction.

Visser TJ, Mol JA, Otten MH.

Endocrinology. 1983 Apr;112(4):1547-9. No abstract available.

PMID:
6832060
46.

The role of dietary fat in peripheral thyroid hormone metabolism.

Otten MH, Hennemann G, Docter R, Visser TJ.

Metabolism. 1980 Oct;29(10):930-5.

PMID:
7421583
47.

[Intestinal bacteria and colonic neoplasms].

Otten MH, Gyr K.

Ther Umsch. 1980 Mar;37(3):201-8. Review. German. No abstract available.

PMID:
6246650
48.

Zollinger-Ellison syndrome treated by endoscopic removal of a duodenal gastrinoma.

Otten MH, Birkenhäger JC, van Blankenstein M.

Neth J Med. 1978;21(6):248-51. No abstract available.

PMID:
732916

Supplemental Content

Loading ...
Support Center